A detailed history of Cwm, LLC transactions in Lucid Diagnostics Inc. stock. As of the latest transaction made, Cwm, LLC holds 1,761 shares of LUCD stock, worth $1,338. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,761
Previous 1,761 -0.0%
Holding current value
$1,338
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 05, 2024

BUY
$0.81 - $1.52 $1,426 - $2,676
1,761 New
1,761 $1,000
Q4 2022

Feb 01, 2023

SELL
$1.21 - $2.27 $121 - $227
-100 Reduced 4.95%
1,920 $3,000
Q2 2022

Jul 28, 2022

BUY
$1.73 - $3.44 $3,494 - $6,948
2,020 New
2,020 $5,000
Q1 2022

Apr 21, 2022

SELL
$2.85 - $5.24 $570 - $1,048
-200 Closed
0 $0
Q4 2021

Jan 31, 2022

BUY
$4.87 - $11.76 $974 - $2,352
200 New
200 $1,000

Others Institutions Holding LUCD

About Lucid Diagnostics Inc.


  • Ticker LUCD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 38,568,500
  • Market Cap $29.3M
  • Description
  • Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. The company focuses on patients with gastroesophageal reflux disease, which is also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarc...
More about LUCD
Track This Portfolio

Track Cwm, LLC Portfolio

Follow Cwm, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.